申请人:Merck Patent GmbH
公开号:US10329270B2
公开(公告)日:2019-06-25
The present invention relates to pyridine, pyrimidine, pyrazine, and pyridazine compounds, and pharmaceutically acceptable compositions thereof, useful as BTK inhibitors.
本发明涉及可用作 BTK 抑制剂的吡啶、嘧啶、吡嗪和哒嗪化合物及其药学上可接受的组合物。